TWO YEARS EFFECTIVENESS OF RITUXIMAB IN REFRACTORY IDIOPATHIC THROM-BOCYTOPENIC PURPURA
Background and aim: The treatment of immune thrombocytopenia (ITP) started with steroids but most patients will relapse or have significant adverse effects. The use of Rituximab was greeted enthusiastically: it led to up to 60% response rates, making it the main alternative to splenectomy, with far...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Medsci Publications
2019-09-01
|
| Series: | National Journal of Medical Research |
| Subjects: | |
| Online Access: | http://njmr.in/index.php/file/article/view/131 |